Read + Share
Zhou N, Velez MA, Bachrach B, Gukasyan J, et al. Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event
post-treatment in NSCLC. Lung Cancer 2021;161:34-41.
PMID: 34507111
|
 |
|
Zhou N, Velez MA, Bachrach B, Gukasyan J, et al. Immune checkpoint inhibitor induced thyroid dysfunction is a frequent event
post-treatment in NSCLC. Lung Cancer 2021;161:34-41.
PMID: 34507111
|
|
|
|